91 related articles for article (PubMed ID: 18648351)
41. Risks of Venous Thromboembolism and Mortality Associated With Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated Anemia.
Samaras AT; Bennett CL
Am J Hematol Oncol; 2008 Aug; 7(8):327-332. PubMed ID: 21850277
[No Abstract] [Full Text] [Related]
42. Review: erythropoiesis-stimulating agents increase mortality in patients with cancer.
Matulonis U
Evid Based Med; 2009 Dec; 14(6):182. PubMed ID: 19949184
[No Abstract] [Full Text] [Related]
43. Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials".
Karnon J; Brennan A; Chilcott J
Eur J Health Econ; 2003 Sep; 4(3):239-40. PubMed ID: 15609191
[No Abstract] [Full Text] [Related]
44. Commentary: do guidelines influence physician practice behavior? The experience with erythropoiesis-stimulating agents.
Neubauer M; Beveridge RA; Kolodziej M
J Oncol Pract; 2009 Sep; 5(5):243-4. PubMed ID: 20856736
[No Abstract] [Full Text] [Related]
45. The burden and predictors of venous thromboembolic diseases in patients with multiple primary malignancies.
Alhamadh MS; Alanazi RB; Alqirnas MQ; Alhabeeb AY; Chachar YS; Alkaiyat M; Sabatin F
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1742. PubMed ID: 36314077
[TBL] [Abstract][Full Text] [Related]
46. Patterns of care in Jehovah's Witnesses patients with solid tumours and lymphoma.
Chang Lee R; Sukumaran S; Koczwara B; Woodman R; Kichenadasse G; Roy A; Vatandoust S; Karapetis C
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1148. PubMed ID: 32721085
[TBL] [Abstract][Full Text] [Related]
47. Erythropoietin or darbepoetin for patients with cancer.
Tonia T; Mettler A; Robert N; Schwarzer G; Seidenfeld J; Weingart O; Hyde C; Engert A; Bohlius J
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003407. PubMed ID: 23235597
[TBL] [Abstract][Full Text] [Related]
48. Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases.
Oh SY; Kim SH; Kwon HC; Lee S; Kim KH; Kwon KA; Lee JH; Lee KY; Kim HJ
Support Care Cancer; 2010 Oct; 18(10):1341-6. PubMed ID: 19841950
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.
Sirén AL; Fasshauer T; Bartels C; Ehrenreich H
Neurotherapeutics; 2009 Jan; 6(1):108-27. PubMed ID: 19110203
[TBL] [Abstract][Full Text] [Related]
50. Risk of venous thromboembolism with the erythropoiesis-stimulating agents (ESAs) for the treatment of cancer-associated anemia: a meta-analysis of randomized control trials.
Zhan P; Wang Q; Qian Q; Yu LK
Chin Clin Oncol; 2012 Dec; 1(2):19. PubMed ID: 25841397
[TBL] [Abstract][Full Text] [Related]
51. VTE and mortality associated with erythropoiesis-stimulating agents in cancer-associated anemia.
Dronca RS; Steensma DP
Nat Clin Pract Oncol; 2008 Sep; 5(9):504-5. PubMed ID: 18648351
[TBL] [Abstract][Full Text] [Related]
52. Tumor progression associated with erythropoiesis-stimulating agents.
Newland AM; Black CD
Ann Pharmacother; 2008 Dec; 42(12):1865-70. PubMed ID: 19017828
[TBL] [Abstract][Full Text] [Related]
53. Is intravenous iron supplementation with erythropoiesis-stimulating agents beneficial in cancer patients with anemia?
Bohlius J
Nat Clin Pract Oncol; 2008 Dec; 5(12):688-9. PubMed ID: 18936789
[TBL] [Abstract][Full Text] [Related]
54. Update on erythropoiesis-stimulating agents and clinical trials in oncology.
Aapro M; Spivak JL
Oncologist; 2009; 14 Suppl 1():6-15. PubMed ID: 19762512
[TBL] [Abstract][Full Text] [Related]
55. Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer.
Juneja V; Keegan P; Gootenberg JE; Rothmann MD; Shen YL; Lee KY; Weiss KD; Pazdur R
Clin Cancer Res; 2008 Jun; 14(11):3242-7. PubMed ID: 18519748
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
